Georgia Melenikiotou Inspire Medical Systems, Inc. (INSP) insider trading activity

Georgia Melenikiotou is Director of Inspire Medical Systems, Inc.. Currently has a direct ownership of 2,213 shares of INSP, which is worth approximately $422,041. The most recent transaction as insider was on Oct 14, 2024, when has been sold 79 shares (Common Stock) at a price of $210.46 per share, resulting in proceeds of $16,626. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.21K

3.7% 3M change

78.47% 12M change

Total Value Held $422,041

Georgia Melenikiotou Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 14 2024	BUY Grant, award, or other acquisition	$16,626 $210.46 p/Share	79 Added 3.45%	2,213 Common Stock
Jul 15 2024	BUY Grant, award, or other acquisition	$4,434 $138.58 p/Share	32 Added 1.48%	2,134 Common Stock
May 02 2024	BUY Grant, award, or other acquisition	-	716 Added 25.41%	2,102 Common Stock
Apr 12 2024	BUY Grant, award, or other acquisition	$12,977 $231.74 p/Share	56 Added 3.88%	1,386 Common Stock
Jan 16 2024	BUY Grant, award, or other acquisition	$19,874 $220.83 p/Share	90 Added 6.34%	1,330 Common Stock
Oct 13 2023	BUY Grant, award, or other acquisition	$13,692 $150.47 p/Share	91 Added 6.84%	1,240 Common Stock
Jul 17 2023	BUY Grant, award, or other acquisition	$13,688 $325.91 p/Share	42 Added 3.53%	1,149 Common Stock
Apr 27 2023	BUY Grant, award, or other acquisition	-	669 Added 37.67%	1,107 Common Stock
Apr 10 2023	BUY Grant, award, or other acquisition	$13,674 $231.77 p/Share	59 Added 11.87%	438 Common Stock
Jan 10 2023	BUY Grant, award, or other acquisition	$13,657 $248.31 p/Share	55 Added 12.67%	379 Common Stock
Oct 11 2022	BUY Grant, award, or other acquisition	$13,687 $168.98 p/Share	81 Added 20.0%	324 Common Stock
Jul 11 2022	BUY Grant, award, or other acquisition	$13,570 $193.86 p/Share	70 Added 22.36%	243 Common Stock
Apr 08 2022	BUY Grant, award, or other acquisition	$13,720 $254.08 p/Share	54 Added 23.79%	173 Common Stock
Jan 10 2022	BUY Grant, award, or other acquisition	$13,654 $227.56 p/Share	60 Added 33.52%	119 Common Stock
Oct 08 2021	BUY Grant, award, or other acquisition	$13,631 $231.04 p/Share	59 Added 50.0%	59 Common Stock
Aug 20 2021	SELL Open market or private sale	$120,071 $212.14 p/Share	566 Reduced 100.0%	0 Common Stock
Aug 20 2021	BUY Exercise of conversion of derivative security	$39,678 $93.14 p/Share	426 Added 42.94%	566 Common Stock
Aug 19 2021	SELL Open market or private sale	$28,976 $206.97 p/Share	140 Reduced 50.0%	140 Common Stock
Aug 18 2021	SELL Open market or private sale	$176,432 $207.08 p/Share	852 Reduced 75.27%	280 Common Stock
Aug 18 2021	BUY Exercise of conversion of derivative security	$79,355 $93.14 p/Share	852 Added 42.94%	1,132 Common Stock
Jul 09 2021	BUY Grant, award, or other acquisition	$13,187 $185.73 p/Share	71 Added 20.23%	280 Common Stock
Apr 09 2021	BUY Grant, award, or other acquisition	$12,452 $218.45 p/Share	57 Added 21.43%	209 Common Stock
Jan 08 2021	BUY Grant, award, or other acquisition	$12,422 $194.1 p/Share	64 Added 29.63%	152 Common Stock
Oct 09 2020	BUY Grant, award, or other acquisition	$11,440 $130.0 p/Share	88 Added 50.0%	88 Common Stock

Also insider at

LUNG

Pulmonx Corp Healthcare